NY0116 (3-30 mg/kg; SC; ; for 14 days) decreases bodyweight, visceral adipose tissue, and cholesterol on a high‐fat diet[1].
| Animal Model: | Male diet induced obese (DIO) C57BL/6J mice age 18 weeks and 8 age[1] |
| Dosage: | 3, 10, 30 mg/kg |
| Administration: | Subcutaneous injection; for 14 days |
| Result: | Significantly decreased bodyweight compared to vehicle, whereas mice were maintained on a high-fat diet. |
